Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 par value per share
-
Shares outstanding
-
73,819,979
-
Number of holders
-
81
-
Total 13F shares, excl. options
-
10,023,314
-
Shares change
-
+82,825
-
Total reported value, excl. options
-
$262,675,920
-
Value change
-
-$4,620,967
-
Put/Call ratio
-
19%
-
Number of buys
-
47
-
Number of sells
-
-25
-
Price
-
$26.21
Significant Holders of RELMADA THERAPEUTICS, INC. - Common Stock, par value $0.001 par value per share (RLMD) as of Q3 2021
108 filings reported holding RLMD - RELMADA THERAPEUTICS, INC. - Common Stock, par value $0.001 par value per share as of Q3 2021.
RELMADA THERAPEUTICS, INC. - Common Stock, par value $0.001 par value per share (RLMD) has 81 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10,023,314 shares
of 73,819,979 outstanding shares and own 13.58% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (1,538,026 shares), VR Adviser, LLC (1,387,720 shares), BlackRock Inc. (1,210,241 shares), VANGUARD GROUP INC (914,723 shares), PARSONS CAPITAL MANAGEMENT INC/RI (472,974 shares), MORGAN STANLEY (449,337 shares), CITADEL ADVISORS LLC (375,852 shares), STATE STREET CORP (325,871 shares), MILLENNIUM MANAGEMENT LLC (254,580 shares), and GEODE CAPITAL MANAGEMENT, LLC (253,703 shares).
This table shows the top 81 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.